Bone Scintigraphy and SPECT/CT of Bisphosphonate-Induced Osteonecrosis of the Jaw

被引:69
|
作者
Dore, Franca [1 ]
Filippi, Luca [1 ]
Biasotto, Matteo [2 ]
Chiandussi, Silvia [2 ]
Cavalli, Fabio [3 ]
Di Lenarda, Roberto [2 ]
机构
[1] Hosp Maggiore Trieste, Nucl Med Sect, Trieste, Italy
[2] Univ Trieste, Sect Dent Sci, Trieste, Italy
[3] Hosp Maggiore Trieste, Sect Radiodiagnost Imaging, Trieste, Italy
关键词
bone scintigraphy; SPECT/CT; jaw; osteonecrosis; EMISSION-TOMOGRAPHY; SKELETAL LESIONS; RISK-FACTORS; CANCER; CT; ASSOCIATION;
D O I
10.2967/jnumed.107.048785
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Endovenous bisphosphonate therapy seems associated with osteonecrosis of the jaw. The aim of this study was to evaluate the additional diagnostic value of hybrid SPECT/CT in (99m)Tc-methylene diphosphonate 3-phase bone scintigraphy of osteonecrosis of the jaw in bisphosphonate-treated patients. Methods: We studied 15 patients (12 women and 3 men) with extraoral tumors affected by lytic bone metastases and multiple myeloma. All patients were previously treated with intravenous bisphosphonates (zoledronic acid) for 1-3 y, were negative for dental disease at clinical examination, and had suspected osteonecrosis of the jaw. All 15 patients underwent panoramic x-ray orthopantomography, CT or MRI (or both), microbiologic examination, 3-phase bone scintigraphy, and SPECT/CT of the maxillary region. Results: Three-phase bone-scintigraphy showed increased perfusion and an increased blood pool in 9 of 12 and 10 of 12 patients, respectively; at the metabolic phase, SPECT was positive in all patients and showed abnormal hyperactivity in the maxilla of 2 patients, in the mandible of 9 patients, and in both the mandible and the maxilla of 4 patients. Hybrid SPECT/CT was of particular value in 8 of 15 patients, allowing discrimination of the osteonecrotic core from nearby hyperactivity due to viable bone. Whole-body scintigraphy showed remote and multiple metastases in all patients. Orthopantomography showed nonspecific bone rarefaction in all patients but was not able to aid diagnosis of osteonecrosis of the jaw. CT and MRI showed anomalies in all symptomatic patients: CT was helpful in evaluating both cortical and trabecular bone aspects, and MRI was able to detect soft-tissue involvement but not cortical bone destruction. Conclusion: In appropriately selected oncology patients treated with bisphosphonates, an increased uptake of (99m)Tc-methylene diphosphonate in maxillary bones may suggest probable osteonecrosis of the jaw. In such cases, SPECT/CT may be of value in increasing the diagnostic accuracy of bone scanning, providing a precise functional anatomic correlation for the definition of the extent of disease.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 50 条
  • [41] Bisphosphonate-induced osteonecrosis of the jaw: Incidence and risk factors in patients with breast cancer and gynecological malignancies
    Beck, V.
    Solomayer, E.
    Krimmel, M.
    Reinert, C.
    Fehm, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Descending necrotizing mediastinitis after sequestrectomy in a patient with bisphosphonate-induced osteonecrosis of the jaw: A case report
    Tamanuki, Tamaki
    Aoyagi, Tomoyoshi
    Murano, Akiyuki
    Matsuzaki, Hiroshi
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (02) : 215 - 218
  • [43] Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone
    Abtahi, Jahan
    Agholme, Fredrik
    Sandberg, Olof
    Aspenberg, Per
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2012, 41 (06) : 494 - 499
  • [44] Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. no primary necrosis in unexposed bone
    Aspenberg, P.
    Abtahi, J.
    Agholme, F.
    Sandberg, O.
    [J]. BONE, 2012, 50 : S173 - S173
  • [45] Reconstruction of Defects Caused by Bisphosphonate-Induced Osteonecrosis of the Jaws
    Marx, Robert E.
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (05) : 107 - 119
  • [46] Hyperbaric oxygen in addition to antibiotic therapy is effective for bisphosphonate-induced osteonecrosis of the jaw in a patient with multiple myeloma
    Shimura, Kazuho
    Shimazaki, Chihiro
    Taniguchi, Kyoko
    Akamatsu, Sonoko
    Okamoto, Masashi
    Uchida, Ryo
    Nomura, Ken-ichi
    Inaba, Tohru
    Horiike, Shigeo
    Kanamura, Narisato
    Taniwaki, Masafumi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (04) : 343 - 345
  • [47] Bacterial promotion of bisphosphonate-induced osteonecrosis in Wistar rats
    Tsurushima, H.
    Kokuryo, S.
    Sakaguchi, O.
    Tanaka, J.
    Tominaga, K.
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2013, 42 (11) : 1481 - 1487
  • [48] Bone SPECT/CT in prevention of Osteonecrosis of Jaw in patients planned for bisphosphonates
    De Gaudio, C.
    Ciliberti, V.
    Pellegrini, M.
    Tarchi, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S367 - S368
  • [49] IMMUNOHISTOCHEMICAL EVALUATION OF SARCOGLYCANS AND INTEGRIN IN GINGIVAL EPITHELIUM OF MULTIPLE MYELOMA PATIENTS WITH BISPHOSPHONATE-INDUCED OSTEONECROSIS OF THE JAW
    Allegra, A.
    Russo, S.
    Cannavo, A.
    Alonci, A.
    Oteri, G.
    Favaloro, A.
    Nastro, E.
    De Ponte, F. S.
    Cicciu, D.
    Anastasi, G.
    Musolino, C.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 379 - 379
  • [50] Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw
    Mathai P.C.
    Andrade N.N.
    Aggarwal N.
    Nerurkar S.
    Kapoor P.
    [J]. Oral and Maxillofacial Surgery, 2018, 22 (2) : 235 - 240